Apomab: Phase Ib started

Roche began an open-label Phase Ib trial to evaluate IV Apomab in combination with FOLFOX chemotherapy and Avastin bevacizumab in 23 patients. Avastin is marketed by Roche's Genentech unit in the U.S...